Related Experiment Video
Updated: Jun 12, 2025
08:58
Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
Published on: July 10, 2018
42.8K
Gasping for air: HIF2α in asthma
Shilpi Giri1, Amanda C Poholek1
1Center for Systems Immunology, Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Immunity
|December 11, 2024
Summary
T helper 2 (Th2) cells drive allergic asthma inflammation. A new study shows hypoxia-inducible factor 2-alpha (HIF2α) promotes inflammatory Th2 cell differentiation, offering a potential therapeutic target for asthma.
Area of Science:
- Immunology
- Molecular Biology
- Respiratory Medicine
Background:
- T helper 2 (Th2) cells play a dual role, offering protection in infections and wound healing, but also driving inflammation in allergic asthma.
- Understanding the molecular mechanisms that promote inflammatory Th2 cell differentiation is crucial for developing effective asthma treatments.
Purpose of the Study:
- To investigate the role of hypoxia-inducible factor (HIF)2α in the differentiation of inflammatory Th2 cells.
- To explore HIF2α as a potential therapeutic target for allergic asthma.
Main Methods:
- The study involved analyzing the differentiation pathways of Th2 cells.
- Investigated the expression and function of HIF2α in the context of Th2 cell development.
Main Results:
- Zou et al. demonstrate the crucial involvement of hypoxia-inducible factor (HIF)2α in promoting the differentiation of inflammatory Th2 cells.
- Findings suggest HIF2α is a key factor in the development of Th2-mediated allergic inflammation.
Conclusions:
- Hypoxia-inducible factor (HIF)2α is a critical regulator in the differentiation of inflammatory Th2 cells.
- HIF2α presents a promising therapeutic target for the treatment of allergic asthma.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:20Asthma: Pathogenesis and Management
364
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
364
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:19Antiasthma Drugs: Leukotriene Modifiers
252
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
252
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
245
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
245
01:24Antiasthma Drugs: Methylxanthines
206
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
206